Elsevier Applications of Nanotechnology in Drug Discovery and Delivery (Drug Discovery Update)

Product Description Applications of Nanotechnology in Drug Discovery and Delivery, in the Drug Discovery Update series, presents complete coverage of the application of nanotechnology in the discovery of new drugs and efficient target delivery of drugs. The book highlights recent advances of nanotechnology applications in the biomedical sciences, starting with chapters that provide the basics of nanotechnology, nanoparticles and nanocarriers. Part II deals with the application of nanotechnology in drug discovery, with an emphasis on enhanced delivery of pharmaceutical products, with Part III discussing toxicological and safety issues arising from the use of nanomaterials. This book brings together a global team of experts, making it an essential resource for researchers, drug developers, medicinal chemists, toxicologists and analytical chemists. Review Presents complete coverage of the application of nanotechnology in the discovery of new drugs and efficient target delivery of drugs From the Back Cover <p><i>Application of Nanotechnology in Drug Discovery and Delivery</i> presents complete coverage of the application of nanotechnology in the discovery of new drugs and efficient target delivery of drugs. The field of nanotechnology is evolving and the application of innovative techniques in different areas of biomedical science is needed. This book highlights recent advances of nanotechnology application in biomedical sciences starting with chapters that provides the basics of nanotechnology, nanoparticles and nanocarriers. Part II presents chapters that deal with the application of nanotechnology in drug discovery with an emphasis on factors to be considered for enhanced delivery of pharmaceutical products. Part III discusses toxicological and safety issues arising from the use of nanomaterials. A volume in <i>Drug Discovery Update</i>, this book brings together a global team of experts and is an essential resource for researchers, drug developers, medicinal chemists, toxicologists, and analytical chemists. </p> About the Author Chukwuebuka Egbuna is a chartered chemist, a chemical analyst, and an academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), the Society of Quality Assurance (SQA) (USA), and the Royal Society of Chemistry (RSC) (United Kingdom). Egbuna is also an editor of new Elsevier series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery, including emerging therapeutic claims for the treatment of diseases. He has been engaged in a number of roles at New Divine Favor Pharmaceutical Industry Limited, Akuzor Nkpor, Anambra State, Nigeria, and Chukwuemeka Odumegwu Ojukwu University (COOU) in Nigeria. He has collaboratively worked and published quite a number of research articles in the area of phytochemistry, nutrition and toxicology and related areas. He is a reviewer and editorial board member of various journals, including serving as a website administrator for the Tropical Journal of Applied Natural Sciences (TJANS), a journal of the faculty of Natural Sciences, COOU and as an advisory board member under toxicology for the book publisher, Cambridge Scholar Publishing. His primary research interests are in phytochemistry, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry. Mihnea-Alexandru Gaman received his M.D. at the Faculty of Medicine, “Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. Dr. Gaman is currently specialising in Clinical Haematology at the Department of Haematology, Centre of Haematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania. Dr. Gaman conducts research in the fields of Haematology, Oncology, Molecular and Cell Biology, Internal Medicine, Pharmacology, Pharmacy and Pharmaceutical Scienc